Regnum

Regnum Equity Growth

The Year-over-Year Equity Growth of Regnum (RGMP) as of Oct 18, 2026 is -205.26 %. In the previous year, Year-over-Year Equity Growth was -660.00 % — a change of -68.90% (higher).

Equity Growth

-205.26 %

YoY

-68.90%

Last updated:

Year-over-Year Equity Growth of Regnum is 2022 -205.26 % . Year-over-Year Equity Growth of Regnum was 2021 -660.00 % . It decreases by -68.90% higher compared to the previous year.

The Regnum Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
300.00 USD
Jan 1, 2019
-75.00 USD
Jan 1, 2020
-600.00 USD
Jan 1, 2021
-660.00 USD
Jan 1, 2022
-205.26 USD
The Regnum Equity Growth history
YEAREquity GrowthYoY
-205.26 %-68.90%
-660.00 %+10.00%
-600.00 %+700.00%
-75.00 %-125.00%
300.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Regnum Stock analysis

What does Regnum do? Regnum Corp, headquartered in New York City, develops and commercializes therapeutics for rare and infectious diseases. The company's primary asset is the U.S. commercial rights to leronlimab (PRO 140), a monoclonal antibody targeting the CCR5 receptor to block R5 strains of HIV. Listed on 15 March 2019, Regnum focuses on entry inhibitor therapies that prevent HIV from entering healthy cells by binding to CCR5. Regnum is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Regnum stock

Year-over-Year Equity Growth of Regnum is -205.26 % in 2022.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Regnum since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Regnum historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Regnum

All Key Metrics — Regnum